AIA is dependent on JNK-1, but not JNK-2. JNK-1 is a promising molecular target for reducing autoimmune inflammation, since its inhibition impairs macrophage migration.
John L. Stebbins, Surya K. De, Thomas Machleidt, Barbara Becattini, Jesús Vázquez, Christian Kuntzen, Li‐Hsing Chen, Jason Cellitti, Megan Riel‐Mehan, Aras Emdadi, Giovanni Solinas, Michael Karin, Maurizio Pellecchia
Elizabeth Webster, Ruth M. Barrientos, Carlo Contoreggi, Mitchel G Isaac, Sophie Ligier, K. Eddie Gabry, George Chrousos, Edward F. McCarthy, Kenner C. Rice, Philip W. Gold, Esther M. Sternberg
Discussion(0)
No comments yet. Be the first to comment.